HMC

Harvard Management Company Portfolio holdings

AUM $1.44B
This Quarter Return
-4.77%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$804M
AUM Growth
+$804M
Cap. Flow
+$232M
Cap. Flow %
28.91%
Top 10 Hldgs %
81.16%
Holding
47
New
2
Increased
2
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Communication Services 47.87%
2 Healthcare 20.16%
3 Consumer Discretionary 14.29%
4 Technology 12.77%
5 Industrials 3.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RKLB icon
26
Rocket Lab Corporation Common Stock
RKLB
$23.4B
$4.07M 0.51%
1,000,000
FULC icon
27
Fulcrum Therapeutics
FULC
$351M
$3.32M 0.41%
410,714
AFRM icon
28
Affirm
AFRM
$28.8B
$3.26M 0.41%
173,560
CFLT icon
29
Confluent
CFLT
$6.85B
$3.1M 0.39%
130,383
SANA icon
30
Sana Biotechnology
SANA
$777M
$2.81M 0.35%
468,749
GBIO icon
31
Generation Bio
GBIO
$40.4M
$2.71M 0.34%
510,354
VIGL
32
DELISTED
Vigil Neuroscience
VIGL
$2.63M 0.33%
289,460
TNGX icon
33
Tango Therapeutics
TNGX
$747M
$2.56M 0.32%
708,385
PCTTW
34
PureCycle Technologies, Inc. Warrant
PCTTW
$844M
$2.43M 0.3%
714,285
TNYA icon
35
Tenaya Therapeutics
TNYA
$184M
$1.95M 0.24%
673,270
KITT icon
36
Nauticus Robotics
KITT
$38.2M
$1.81M 0.22%
+500,000
New +$1.81M
PRAX icon
37
Praxis Precision Medicines
PRAX
$958M
$1.77M 0.22%
778,517
SRZN icon
38
Surrozen
SRZN
$104M
$1.67M 0.21%
826,852
DYN icon
39
Dyne Therapeutics
DYN
$1.92B
$1.36M 0.17%
107,252
PACB icon
40
Pacific Biosciences
PACB
$393M
$1.33M 0.17%
229,144
XLO icon
41
Xilio Therapeutics
XLO
$36.3M
$1.21M 0.15%
416,059
DBTX
42
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.14M 0.14%
328,798
LAUR icon
43
Laureate Education
LAUR
$4.05B
$1.07M 0.13%
+101,804
New +$1.07M
MCRB icon
44
Seres Therapeutics
MCRB
$166M
$846K 0.11%
131,847
PRDS
45
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$740K 0.09%
400,000
DNTH icon
46
Dianthus Therapeutics
DNTH
$759M
$469K 0.06%
332,610
IRON icon
47
Disc Medicine
IRON
$2.07B
$410K 0.05%
250,000